LVGO News and Press, Livongo Health Inc. From 07/08/20

DexCom (DXCM), Livongo Health (LVGO), and Tandem Diabetes Care (TNDM) are involved in diabetes care, a recession-proof industry. Most people would be shocked to learn that more than 34 million Americans are living with diabetes. That figure represents more than 10% of the country's populati...

Livongo Health (NASDAQ: LVGO) stock has nearly tripled from its initial public offering less than a year ago. Investors may think they've missed out on a great investment, but it's not too late to be part of this long-term growth story. I purchased shares a few weeks ago in this healthcare t...

Shares of Livongo Health (NASDAQ: LVGO) soared on Tuesday, jumping about 20%. The stock's gain came after the company gave investors an early glimpse into its recently ended second quarter. Revenue crushed both its own guidance and analysts' average estimates, management revealed. The grow...

Livongo Health (NASDAQ: LVGO) was already one of the rock-star stocks of 2020, having gained more than 200% so far this year. Expectations were understandably high as the digital health management company released its preliminary second-quarter results, but the numbers far exceeded the mos...

When searching for the best opportunities in the market, hard variables such as revenue growth and profit margins are obviously very important. However, the most crucial return driver for a company over the long term is arguably the quality of the management team. Businesses are built and ru...

Shares of Livongo Health (NASDAQ: LVGO) , which provides a cloud-based platform to help improve the lives of individuals with chronic conditions, jumped higher on Tuesday. The stock was up about 17% as of 10:05 a.m. EDT. The growth stock 's gain follows the company's announcement of it...

Corvus Pharmaceuticals (NASDAQ: CRVS ) +103%  on launch immunotherapy study for COVID-19. More news on: Corvus Pharmaceuticals, Inc., Annovis Bio, Inc., Novavax, Inc., Stocks on the move, , Read more ...

Livongo Health (NASDAQ: LVGO ) expects Q2 2020 revenue in the range of $86M to $87M, up from prior guidance of $73M to $75M. More news on: Livongo Health, Inc., Healthcare stocks news, Stocks on the move, Read more ...

MOUNTAIN VIEW, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO) today announced a preliminary financial result for the second quarter of fiscal year 2020. Livongo now expects revenue for the second quarter of 2020 to be in the range of $86 million to $87 mil...

Regardless of whether you're a longtime investor or someone who recently began putting their money to work in the stock market, there's nothing that could have prepared you for what 2020 has offered up. The coronavirus disease 2019 (COVID-19) pandemic has completely upended societal norms and pu...